Study Overview: This study is to find out if cannabidiol (CBD), a compound from the cannabis plant, can help people with opioid addiction by reducing cravings and anxiety. The study compares two doses of CBD (200mg and 400mg) with a placebo, which is a fake pill with no medicine in it. Participants will take CBD twice a day and be checked for any changes in their cravings, anxiety, and mood.
Who Can Join: Adults aged 18-65 with diagnosed opioid use disorder (OUD) who are already on methadone or buprenorphine treatments are eligible. They should understand and agree to the study rules and be able to take part safely.
Who Cannot Join: People with severe mental health issues, allergies to CBD, or those with other severe substance use disorders are not eligible. Pregnant or breastfeeding women and those in other drug trials can't participate.
NCT06206291
Yasmin Hurd
24 January 2024
,
You have contacted , on
Your message has been sent to the study team at ,
You are contacting
Primary Contact
Congrats! You have your own personal workspace now.